September 19, 2017

Teva has made two separate sales from its global women’s health business in an effort to repay term loan debt. 

September 18, 2017

Solosec is the first approved single-dose oral therapy for bacterial vaginosis. 

September 12, 2017

The legislation aims to make it easier for generics makers to access drug samples of branded products when trying to develop a generic version, many of which are protected by Risk Evaluation and Management Strategies,

September 12, 2017
Recently, patient advocates and regulators have begun acknowledging a need for something to be done about increasing costs of specialty drugs — both for manufacturers and patients. 
 
September 11, 2017

Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO. 

September 8, 2017
The approval means that Admelog has met all requirements for the regulatory agency, pending any patent issues that have not yet been resolved. 
September 5, 2017

Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a Food and Drug Administration decision date of Nov. 29.

September 5, 2017

The company has named its current global head of drug development and chief medical officer, Dr. Vasant Narasimhan, as CEO, effective Feb. 1, 2018.

August 31, 2017

Baricitinib is a once-daily oral investigational medication for the treatment of patients with moderate-to-severe rheumatoid arthritis.

August 31, 2017

Benznidazole is an essential medicine for Chagas disease, a parasitic disease that affects an estimated 6 million to 8 million people worldwide.

August 31, 2017

Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.

August 30, 2017

A recognized expert in clinical research and development, PhRMA's new chief medical officer hails from the U.S. Food and Drug Administration's Center for Drug Evaluation and Research.

August 29, 2017

With more than 10,000 patients enrolled in the study over the last six years, CANTOS was one of the largest and longest-running clinical trials in Novartis' history.

August 29, 2017

Researchers found that women with high cholesterol were 45% less likely to develop breast cancer than those without high cholesterol, suggesting their treatment for high cholesterol may be a factor.

August 28, 2017

There was no evidence of a leveling off of effect and no new safety concerns were identified in this analysis, Amgen reported.

August 23, 2017

Dr. Mark Sigro, who has been BioDelivery Sciences' president and CEO since 2005, will be retiring at the end of the year. 

August 22, 2017

The move potentially reduces the number of vials needed for hemophilia A patients and offers them more treatment options, the company said.

August 22, 2017

The site offers healthcare professionals tools that include an informational video, a guide on how to get started and a patient enrollment form.

August 18, 2017

The drug is indicated to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, or ALL.

August 18, 2017

WILMINGTON, Del. — AstaZeneca and Merck’s Lynzparza (olaparib) tablets were approved by the Food and Drug Administration, as well as given an expanded indication by the regulatory agency.

August 10, 2017

In clinical trials, 33% of patients treated with Radicava showed a lower rate of decline in the loss of physical function, compared with those on a placebo.

August 7, 2017

The company said it’s the only FDA-approved liquid dosage form of potassium-sparing diuretic spironolactone.

August 7, 2017
The QVAR RediHaler is a breath-actuated inhaler for the maintenance of asthma as a prophylactic treatment in patients ages 4 years and older.
August 4, 2017

Vyxeos combines two commonly used chemotherapies into a single formulation to treat patients with certain types of high-risk acute myeloid leukemia.